PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 32 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $469,000 | -39.6% | 1,000,000 | -60.0% | 0.14% | -50.7% |
| Q4 2018 | $777,000 | -57.2% | 2,500,000 | 0.0% | 0.29% | -37.2% |
| Q3 2018 | $1,817,000 | +36.3% | 2,500,000 | -19.4% | 0.46% | +33.9% |
| Q2 2018 | $1,333,000 | -24.3% | 3,100,000 | -4.9% | 0.34% | -31.4% |
| Q1 2018 | $1,760,000 | +45.9% | 3,260,000 | +78.6% | 0.50% | +30.3% |
| Q4 2017 | $1,206,000 | – | 1,825,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,178,440 | $5,338,000 | 5.83% |
| GREAT POINT PARTNERS LLC | 399,007 | $1,808,000 | 1.25% |
| Camber Capital Management LP | 1,790,000 | $8,109,000 | 0.85% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,041,078 | $4,716,000 | 0.43% |
| FEDERATED HERMES, INC. | 10,427,472 | $47,237,000 | 0.18% |
| SILVERBACK ASSET MANAGEMENT LLC | 272,200 | $1,233,000 | 0.10% |
| Catalyst Capital Advisors LLC | 30,000 | $136,000 | 0.07% |
| OBERWEIS ASSET MANAGEMENT INC/ | 54,200 | $246,000 | 0.07% |
| Baillie Gifford | 5,548,351 | $25,134,000 | 0.06% |
| Fore Research & Management, LP | 200,000 | $906,000 | 0.06% |